Insider Trading activities of Adaptive Biotechnologies Corp (ADPT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adaptive Biotechnologies Corp (ADPT) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adaptive Biotechnologies Corp since year 2005. Table 2 shows the detailed insider transactions of Adaptive Biotechnologies Corp since 2005. The reporting company's ticker symbol is ADPT. The reporting company's CIK number is 1478320.
The total value of stock buying since 2005 is $15,244,000.
The total value of stock sales since 2005 is $12,589,084.
The total value of stock option exercises since 2005 is $491,238.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Adaptive Biotechnologies Corp (ADPT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2020-01 0 $0 91,762 $2,684,259 91,762 $206,288
2019-12 0 $0 335,000 $9,904,825 355,000 $278,350
2019-10 0 $0 0 $0 20,000 $6,600
2019-07 762,200 $15,244,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Adaptive Biotechnologies Corp insiders (ADPT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2020-01-17 Robins Harlan S (Chief Scientific Officer) Sale 3,700 27.82 102,915
2020-01-17 Robins Harlan S (Chief Scientific Officer) Option Ex 3,700 6.32 23,384
2020-01-16 Robins Harlan S (Chief Scientific Officer) Sale 3,700 28.77 106,460
2020-01-16 Robins Harlan S (Chief Scientific Officer) Option Ex 3,700 6.32 23,384
2020-01-15 Robins Harlan S (Chief Scientific Officer) Sale 3,700 29.52 109,224
2020-01-15 Robins Harlan S (Chief Scientific Officer) Option Ex 3,700 6.32 23,384
2020-01-08 Taylor Stacy L (SVP and General Counsel) Sale 662 30.00 19,860
2020-01-08 Taylor Stacy L (SVP and General Counsel) Option Ex 662 6.55 4,336
2020-01-08 Cohen Chad M (Chief Financial Officer) Sale 20,000 29.87 597,400
2020-01-08 Cohen Chad M (Chief Financial Officer) Option Ex 20,000 4.07 81,400
2020-01-06 Hill Nancy Louise (SVP, Operations) Sale 60,000 29.14 1,748,400
2020-01-06 Hill Nancy Louise (SVP, Operations) Option Ex 60,000 .84 50,400
2019-12-31 Rubinstein Julie (President) Sale 40,000 30.00 1,200,000
2019-12-31 Rubinstein Julie (President) Option Ex 40,000 .84 33,600
2019-12-31 Dobmeier Eric (Director) Option Ex 5,000 6.32 31,600
2019-12-30 Rubinstein Julie (President) Sale 55,000 28.82 1,584,825
2019-12-30 Rubinstein Julie (President) Option Ex 55,000 .45 24,750
2019-12-27 Rubinstein Julie (President) Sale 80,000 29.28 2,342,400
2019-12-27 Rubinstein Julie (President) Option Ex 80,000 .45 36,000
2019-12-26 Rubinstein Julie (President) Sale 80,000 29.37 2,349,600
2019-12-26 Rubinstein Julie (President) Option Ex 80,000 .39 31,200
2019-12-26 Dobmeier Eric (Director) Option Ex 15,000 6.32 94,800
2019-12-24 Rubinstein Julie (President) Sale 80,000 30.35 2,428,000
2019-12-24 Rubinstein Julie (President) Option Ex 80,000 .33 26,400
2019-10-23 Robins Chad M (CEO and Chairman) Option Ex 20,000 .33 6,600
2019-07-01 Hill Nancy Louise (Sr Vice President, Operations) Buy 11,200 20.00 224,000
2019-07-01 Shabet Rose Sharon Buy 500,000 20.00 10,000,000
2019-07-01 Cohen Chad M (Chief Financial Officer) Buy 1,000 20.00 20,000

Insider trading activities including stock purchases, stock sales, and option exercises of ADPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adaptive Biotechnologies Corp (symbol ADPT, CIK number 1478320) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month